HBOX Therapies
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2023-07-01attributed |
| Founded | 2021 |
| Headquarters | Aachen |
| Industry | medtech |
| Stage | unknown |
| Website | hbox-therapies.com |
HBOX Therapies makes MiRA, an extracorporeal device that oxygenates blood and removes CO2 directly, bypassing the lungs while letting patients keep breathing and recover. It is built for ICU patients in acute respiratory failure who fail non-invasive support. Its hyperbaric gas management and low-damage blood pump aim to be a less invasive alternative to mechanical ventilation.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-07-01 | grant | $2.7M | undisclosed |
Detected tech stack
Apache HTTP Server 2.4.67, UNIX, apache 2.4.67
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | hbox-therapies.com, read 2026-05-07 |
| Description | self-reported | hbox-therapies.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.